Olanzapine:: keep an eye on this neuroleptic -: Response

被引：0
|
作者：
Toussaint, B
机构：
来源：
CANADIAN FAMILY PHYSICIAN | 2000年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：1569 / 1569
页数：1
相关论文
共 50 条
  • [21] Olanzapine usage associated with neuroleptic malignant syndrome
    Philibert, RA
    Adam, LA
    Frank, FM
    Carney-Doebbeling, C
    PSYCHOSOMATICS, 2001, 42 (06) : 528 - 529
  • [22] Atypical neuroleptic malignant syndrome associated with olanzapine
    Reeves, RR
    Torres, RA
    Liberto, V
    Hart, RH
    PHARMACOTHERAPY, 2002, 22 (05): : 641 - 644
  • [23] Neuroleptic Malignant Syndrome Secondary to Olanzapine Use
    Arumairaj, A. J.
    Vista, M.
    Chaudhari, A.
    Lee, S.
    Newman, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [24] Neuroleptic malignant syndrome after the initiation of olanzapine
    Levenson, JL
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1999, 19 (05) : 477 - 478
  • [25] Possible neuroleptic malignant syndrome associated with olanzapine
    Nyfort-Hansen, K
    Alderman, CP
    ANNALS OF PHARMACOTHERAPY, 2000, 34 (05) : 667 - 667
  • [26] Olanzapine-associated neuroleptic malignant syndrome
    Kontaxakis, VP
    Havaki-Kontaxaki, BJ
    Christodoulou, NG
    Paplos, KG
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2002, 26 (05): : 897 - 902
  • [27] Olanzapine-associated neuroleptic malignant syndrome
    Norgard, Nick B.
    Stark, Jennifer E.
    PHARMACOTHERAPY, 2006, 26 (08): : 1180 - 1182
  • [28] Olanzapine induced "typical" neuroleptic malignant syndrome
    Goveas, JS
    Hermida, A
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2003, 23 (01) : 101 - 102
  • [29] Olanzapine-associated neuroleptic malignant syndrome.: A case report and favorable response to risperidone
    Lopez-Torres, E.
    Cobo, I.
    Lucena, M. I.
    ACTAS ESPANOLAS DE PSIQUIATRIA, 2007, 35 (02): : 145 - 146
  • [30] Atypical (olanzapine) plus conventional (fluphenazine) neuroleptic treatment associated with the Neuroleptic Malignant Syndrome
    Tofler, IT
    Ahmed, B
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2003, 23 (06) : 672 - 674
12345